Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Research Biosimilar

Research Grade Sotrovimab (DVV00307)

Host species:Human
Isotype:IgG1, kappa
Applications:Research Grade Biosimilar
Expression system:Mammalian Cells
Overview

Catalog No.

DVV00307

Expression system

Mammalian Cells

Species reactivity

SARS-CoV-2 (2019-nCoV)

Host species

Human

Isotype

IgG1, kappa

Clonality

Monoclonal

Target

Spike glycoprotein, S glycoprotein, E2, Peplomer protein, Spike protein S1, Spike protein S2, Spike protein S2', S, 2

Concentration

3.03 mg/ml

Endotoxin level

Please contact with the lab for this information.

Purity

>95% as determined by SDS-PAGE.

Purification

Protein A/G purified from cell culture supernatant.

Accession

P0DTC2

Applications

Research Grade Biosimilar

Form

Liquid

Storage buffer

0.01M PBS, pH 7.4.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.

Alternative Names

VIR-7831, GSK4182136, S309, CAS: 2423014-07-5

Clone ID

Sotrovimab

Data Image
  • Bioactivity
    Detects RBD in indirect ELISAs.
  • SDS-PAGE
    SDS PAGE for Sotrovimab
  • Bioactivity
    Omicron RBD binds with S309
References

Sotrovimab, PMID: 34165945

An EUA for sotrovimab for treatment of COVID-19, PMID: 34181630

COVID antibody treatments show promise for preventing severe disease, PMID: 33712752

Datasheet

Document Download

Research Grade Sotrovimab.pdf

 

$ 372
Product specifications
100 μg 372 1 mg 1486

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Research Grade Sotrovimab [DVV00307]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2024 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only